Industry Problem
"Lose 47 pounds in 30 days." We are not that brand.
Miracle claims in the weight-loss industry have been the default marketing playbook for decades. GLP-1 telehealth has inherited that playbook — and it needs to stop.
Exaggerated weight loss claims create unrealistic expectations, undermine patient trust, and — when they come from healthcare-adjacent brands — raise serious regulatory and ethical concerns. Real people with real health goals deserve honest information about what a treatment can and cannot do.
Before/after photos without context
Results shown without disclosure of timeline, starting conditions, dosage, or lifestyle factors are misleading by definition.
Celebrity endorsements with no disclosure
Paid partnerships presented as organic testimonials are a FTC violation and a trust violation.
Overstated efficacy language
Describing GLP-1 medications as 'the cure for obesity' or 'guaranteed to work' misrepresents the clinical evidence and the role of lifestyle factors.
Shame-based urgency tactics
Marketing that exploits body image insecurity or creates false urgency ('limited supply — act now') prioritizes conversion over patient wellbeing.
The NoBsRx Answer
Honest information. No miracles. No shame.
NoBsRx does not make weight loss guarantees. We do not use before/after claims, miracle language, or urgency tactics. We provide clear information about the process, publish real pricing, and let licensed providers make clinical decisions. That's the whole pitch.